Suppr超能文献

含磷酸地塞米松的RGD肽脂质体对炎症部位血管生成内皮细胞的靶向作用可抑制实验性关节炎。

Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis.

作者信息

Koning Gerben A, Schiffelers Raymond M, Wauben Marca H M, Kok Robbert J, Mastrobattista Enrico, Molema Grietje, ten Hagen Timo L M, Storm Gert

机构信息

Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

出版信息

Arthritis Rheum. 2006 Apr;54(4):1198-208. doi: 10.1002/art.21719.

Abstract

OBJECTIVE

To investigate whether RGD peptide-exposing long circulating polyethylene glycol (PEG) liposomes (RGD-PEG-L) targeted to alphavbeta3 integrins expressed on angiogenic vascular endothelial cells (VECs) are able to bind VECs at sites of inflammation and whether such liposomes containing dexamethasone phosphate (DEXP) can be used as carriers to interfere with the development of experimental arthritis.

METHODS

Binding and internalization of RGD-PEG-L were studied by fluorescence-activated cell sorting and confocal microscopy using fluorescently labeled liposomes. Radiolabeled liposomes were used to test in vivo pharmacokinetics and inflammation site targeting in lipopolysaccharide (LPS)-induced inflammation and adjuvant-induced arthritis (AIA) in rats. In vivo inflammation targeting was visualized by intravital microscopy using fluorescently labeled RGD-PEG-L. Therapeutic efficacy of DEXP-encapsulating RGD-PEG-L compared with nontargeted liposomes was evaluated in rats with AIA.

RESULTS

RGD-PEG-L bound to and were taken up by proliferating human VECs in vitro. In vivo, increased targeting of radiolabeled RGD-PEG-L to areas of LPS-induced inflammation in rats was observed. Specific association with the blood vessel wall at the site of inflammation was confirmed by intravital microscopy. One single intravenous injection of DEXP encapsulated in RGD-PEG-L resulted in a strong and long-lasting antiarthritic effect in rat AIA.

CONCLUSION

RGD-targeted PEG liposomes represent an endothelial cell-specific drug delivery system that targets VECs at sites of inflammation. Use of these liposomes to deliver DEXP to VECs at arthritis-affected sites proved efficacious in rat adjuvant arthritis. These data indicate that VECs have an essential role in the inflammation process and suggest the possibility of using VEC targeting for therapeutic intervention in inflammatory processes such as arthritis.

摘要

目的

研究靶向血管生成性血管内皮细胞(VECs)上表达的αvβ3整合素的RGD肽修饰的长循环聚乙二醇(PEG)脂质体(RGD-PEG-L)是否能够在炎症部位与VECs结合,以及这种含有磷酸地塞米松(DEXP)的脂质体是否可用作载体来干预实验性关节炎的发展。

方法

使用荧光标记的脂质体,通过荧光激活细胞分选和共聚焦显微镜研究RGD-PEG-L的结合和内化。放射性标记的脂质体用于测试大鼠体内脂多糖(LPS)诱导的炎症和佐剂诱导的关节炎(AIA)中的药代动力学和炎症部位靶向性。使用荧光标记的RGD-PEG-L通过活体显微镜观察体内炎症靶向性。在患有AIA的大鼠中评估了包裹DEXP的RGD-PEG-L与非靶向脂质体相比的治疗效果。

结果

RGD-PEG-L在体外与增殖的人VECs结合并被其摄取。在体内,观察到放射性标记的RGD-PEG-L对大鼠LPS诱导的炎症区域的靶向性增加。活体显微镜证实了在炎症部位与血管壁的特异性结合。单次静脉注射包裹在RGD-PEG-L中的DEXP对大鼠AIA产生了强烈且持久的抗关节炎作用。

结论

RGD靶向的PEG脂质体代表一种内皮细胞特异性药物递送系统,可在炎症部位靶向VECs。将这些脂质体用于在关节炎受累部位将DEXP递送至VECs在大鼠佐剂性关节炎中证明是有效的。这些数据表明VECs在炎症过程中起重要作用,并提示在关节炎等炎症过程中使用VEC靶向进行治疗干预的可能性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验